Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
TEVA Stock Chart & Stats
9628.00
0.44(0.56%)
At close: 4:00 PM EST
9628.00
0.44(0.56%)
Day’s Range― - ―
52-Week Range4,865.00 - 9,938.00
Previous CloseN/A
Volume1.42M
Average Volume (3M)1.92M
Market Cap
110.84B
Enterprise Value124.10B
Total Cash (Recent Filing)2.20B
Total Debt (Recent Filing)17.09B
Price to Earnings (P/E)47.4
Beta0.64
Next Earnings
Jan 28, 2026EPS Estimate
210.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)254.10
Shares Outstanding1,146,838,700
10 Day Avg. Volume1,312,069
30 Day Avg. Volume1,917,294
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)4.70
Price to Sales (P/S)1.53
P/FCF Ratio33.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Teva News
TEVA FAQ
What was Teva Pharmaceutical Industries Limited’s price range in the past 12 months?
Teva Pharmaceutical Industries Limited lowest stock price was 4865.00 and its highest was 9938.00 in the past 12 months.
What is Teva Pharmaceutical Industries Limited’s market cap?
Teva Pharmaceutical Industries Limited’s market cap is 110.84B.
When is Teva Pharmaceutical Industries Limited’s upcoming earnings report date?
Teva Pharmaceutical Industries Limited’s upcoming earnings report date is Jan 28, 2026 which is in 36 days.
How were Teva Pharmaceutical Industries Limited’s earnings last quarter?
Teva Pharmaceutical Industries Limited released its earnings results on Nov 05, 2025. The company reported 254.1 earnings per share for the quarter, beating the consensus estimate of 226.3 by 27.8.
Is Teva Pharmaceutical Industries Limited overvalued?
According to Wall Street analysts Teva Pharmaceutical Industries Limited’s price is currently Overvalued.
Does Teva Pharmaceutical Industries Limited pay dividends?
Teva Pharmaceutical Industries Limited pays a Quarterly dividend of 8.5 which represents an annual dividend yield of N/A. See more information on Teva Pharmaceutical Industries Limited dividends here
What is Teva Pharmaceutical Industries Limited’s EPS estimate?
Teva Pharmaceutical Industries Limited’s EPS estimate is 210.6.
How many shares outstanding does Teva Pharmaceutical Industries Limited have?
Teva Pharmaceutical Industries Limited has 1,146,838,700 shares outstanding.
What happened to Teva Pharmaceutical Industries Limited’s price movement after its last earnings report?
Teva Pharmaceutical Industries Limited reported an EPS of 254.1 in its last earnings report, beating expectations of 226.3. Following the earnings report the stock price went up 17.191%.
Which hedge fund is a major shareholder of Teva Pharmaceutical Industries Limited?
Currently, no hedge funds are holding shares in IL:TEVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty pharmaceuticals. Founded in 1901 and headquartered in Petah Tikva, Israel, Teva operates in more than 60 countries and offers a diverse portfolio of over 3,500 products, including generic medicines, specialty drugs, and over-the-counter products. The company's core focus is on improving patient access to high-quality medications, particularly in therapeutic areas such as central nervous system disorders, oncology, and respiratory conditions.
TEVA Revenue Breakdown
54.45% North America
32.42% Europe
13.12% International Markets
